At TOM Weight Loss we watch the obesity-medicine landscape closely so we can keep you on the most effective, most affordable plan possible. One of the biggest recent shifts: brand-name GLP-1 medications are now available to cash-paying patients at far lower prices through TrumpRx and the manufacturer programs it links to. If you prefer a brand-name, FDA-approved therapy with predictable pricing, this opens a new route, and we can help you use it.

The brand-name prices now available

As of mid-2026, cash pricing for brand-name GLP-1s through these programs runs roughly:

Wegovy (semaglutide): around $349 per month for standard maintenance doses, with introductory pricing near $199 per month for the first fills of lower doses. The oral semaglutide pill starts around $149 per month and ranges up to about $299 depending on dose.
Zepbound (tirzepatide): about $299 per month at the starting dose, rising to roughly $449 and higher for higher doses.

These are substantial reductions from the $1,000-plus monthly prices many patients faced before, and they're expected to ease further over the next couple of years. (For patients on Medicare, a separate GLP-1 weight-loss coverage pathway is also rolling out, and our Medicare GLP-1 bridge can help you navigate it.)

What this means for you as a TOM patient

Once you've been evaluated and you're eligible, we're glad to prescribe brand-name GLP-1s for patients who prefer that route and to coordinate the purchase through the appropriate program. Our team handles the evaluation, confirms the right medication and starting dose for you, and helps you transition smoothly, so the lower pricing actually translates into a plan you can start and stick with.

Compounded medication still has a place

Lower brand-name pricing doesn't make compounded options obsolete. For some patients, compounded semaglutide or tirzepatide remains the better medical choice. For example:

If the brand formulation causes intolerable side effects (injection-site reactions, persistent nausea) or you've run into supply gaps, a more flexible compounded regimen may suit you better.
If you need finer dose adjustment, such as micro-dosing or a slower titration than the brand's fixed dose steps allow, compounding gives your clinician more room to personalize.

Compounded medications are not FDA-approved, and we'll explain that clearly before you choose.

Both pathways, one plan

We maintain both routes (brand-name through TrumpRx-linked programs when it's the right fit, and compounded when it's more appropriate or better tolerated) and we help you compare the real, all-in costs side by side. You can review our membership pricing to see the compounded option. As prices and your own needs change, your plan can change with them, so you're always on the most effective option you can sustain.

If you're in Texas or Utah and want help choosing between brand-name and compounded GLP-1 care, start your consultation and we'll build the plan around you. (This article is educational and not a substitute for personalized medical advice.)

What TOM Patients Can Expect From TrumpRx

The brand-name prices now available

What this means for you as a TOM patient

Compounded medication still has a place

Both pathways, one plan

Sources

Keep reading